Related references
Note: Only part of the references are listed.Pharmacological inhibition of the MEK5/ERK5 and PI3K/Akt signaling pathways synergistically reduces viability in triple-negative breast cancer
Thomas D. Wright et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1
Jie Su et al.
NATURE (2020)
Cancer-associated fibroblasts promote cell growth by activating ERK5/PD-L1 signaling axis in colorectal cancer
Mengyan Zhang et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Extracellular signal regulated kinase 5 promotes cell migration, invasion and lung metastasis in a FAK-dependent manner
Weiwei Jiang et al.
PROTEIN & CELL (2020)
Efficient Suppression of NRAS-Driven Melanoma by Co-Inhibition of ERK1/2 and ERK5 MAPK Pathways
Christian Adam et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors
Pamela A. Lochhead et al.
NATURE COMMUNICATIONS (2020)
EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis
Anthony Genna et al.
CANCERS (2020)
ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer
Van T Hoang et al.
FRONTIERS IN ONCOLOGY (2020)
Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression
Dona Sinha et al.
BIOMOLECULES (2020)
Resistance to MAPK Inhibitors in Melanoma Involves Activation of the IGF1R-MEK5-Erk5 Pathway
Lucia Benito-Jardon et al.
CANCER RESEARCH (2019)
CRISPR/Cas9 engineering of ERK5 identifies its FAK/PYK2 dependent role in adhesion-mediated cell survival
Moazzam Ali et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer
Veronica Moncho-Amor et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
TGF--Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
Yang Hao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Novel Diphenylamine Analogs Induce Mesenchymal to Epithelial Transition in Triple Negative Breast Cancer
Akshita B. Bhatt et al.
FRONTIERS IN ONCOLOGY (2019)
Mechanochemical Signaling of the Extracellular Matrix in Epithelial-Mesenchymal Transition
Lewis E. Scott et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
被撤回的出版物: Resveratrol Reverses Cigarette Smoke-Induced Urocystic Epithelial-Mesenchymal Transition via Suppression of STAT3 Phosphorylation in SV-HUC-1-Immortalized Human Urothelial Cells (Retracted article. See vol. 16, pg. 277, 2023)
Hongliang Sun et al.
ONCOTARGETS AND THERAPY (2019)
MEK5/ERK5 activation regulates colon cancer stem-like cell properties
Diane M. Pereira et al.
CELL DEATH DISCOVERY (2019)
Extracellular signal regulated kinase 5 and inflammasome in progression of mesothelioma
Joyce K. Thompson et al.
ONCOTARGET (2018)
SATB2 targeted by methylated miR-34c-5p suppresses proliferation and metastasis attenuating the epithelial-mesenchymal transition in colorectal cancer
Jingfeng Gu et al.
CELL PROLIFERATION (2018)
A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis
Simona Pavan et al.
ONCOGENE (2018)
ERK5 is activated by oncogenic BRAF and promotes melanoma growth
Ignazia Tusa et al.
ONCOGENE (2018)
A CRISPR screen identifies MAPK7 as a target for combination with MEK inhibition in KRAS mutant NSCLC
Nicholas Dompe et al.
PLOS ONE (2018)
Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition
Emanuele Giurisato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The Epithelial-to-Mesenchymal Transition in Cancer
Joelle Roche
CANCERS (2018)
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells
Ignazia Tusa et al.
STEM CELL REPORTS (2018)
KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism
Angelina V. Vaseva et al.
CANCER CELL (2018)
Genetic dissection of the miR-200-Zeb1 axis reveals its importance in tumor differentiation and invasion
Alexandra C. Title et al.
NATURE COMMUNICATIONS (2018)
Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis
Fang Liu et al.
ONCOLOGY REPORTS (2017)
Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells
Zhiqi Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
DCLK1 is correlated with MET and ERK5 expression, and associated with prognosis in malignant pleural mesothelioma
Hui Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Role of AP-2α and MAPK7 in the regulation of autocrine TGF-β/miR-200b signals to maintain epithelial-mesenchymal transition in cholangiocarcinoma
Dawei Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
ERK5 regulates tobacco smoke-induced urocystic epithelial-mesenchymal transition in BALB/c mice
Jie Min et al.
MOLECULAR MEDICINE REPORTS (2017)
EMT and inflammation: inseparable actors of cancer progression
Meggy Suarez-Carmona et al.
MOLECULAR ONCOLOGY (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
An epithelial-to-mesenchymal transition-inducing potential of granulocyte macrophage colony-stimulating factor in colon cancer
Yaqiong Chen et al.
SCIENTIFIC REPORTS (2017)
Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma
Chengli Song et al.
SCIENTIFIC REPORTS (2017)
MiR-143 regulates the proliferation and migration of osteosarcoma cells through targeting MAPK7
Xiancheng Dong et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2017)
Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten-Deficient Mouse Model of Prostate Carcinogenesis
Carolyn J. Loveridge et al.
CANCER RESEARCH (2017)
MAPK7 Gene Controls Proliferation, Migration and Cell Invasion in Osteosarcoma
Francine Tesser-Gamba et al.
MOLECULAR CARCINOGENESIS (2016)
miR-143 suppresses epithelial-mesenchymal transition and inhibits tumor growth of breast cancer through down-regulation of ERK5
Limin Zhai et al.
MOLECULAR CARCINOGENESIS (2016)
MicroRNA-200b-3p suppresses epithelial-mesenchymal transition and inhibits tumor growth of glioma through down-regulation of ERK5
Jianguo Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Platelet-derived growth factor (PDGF)-induced activation of Erk5 MAP-kinase is dependent on Mekk2, Mek1/2, PKC and PI3-kinase, and affects BMP signaling
Maria Tsioumpekou et al.
CELLULAR SIGNALLING (2016)
Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer
Priya S. Mathur et al.
MOLECULAR CANCER RESEARCH (2016)
ERα-XPO1 Cross Talk Controls Tamoxifen Sensitivity in Tumors by Altering ERK5 Cellular Localization
Kinga Wrobel et al.
MOLECULAR ENDOCRINOLOGY (2016)
CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5-AP-1 axis
Kangmin Zhuang et al.
CELL DEATH & DISEASE (2016)
ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation
Petrus R. de Jong et al.
NATURE COMMUNICATIONS (2016)
Absence of ERK5/MAPK7 delays tumorigenesis in Atm-/- mice
Alba Granados-Jaen et al.
ONCOTARGET (2016)
ERK5 Is a Critical Mediator of Inflammation-Driven Cancer
Katherine G. Finegan et al.
CANCER RESEARCH (2015)
FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7
Yu-Pan Bai et al.
CANCER SCIENCE (2015)
The MAPK ERK5, but not ERK1/2, inhibits the progression of monocytic phenotype to the functioning macrophage
Xuening Wang et al.
EXPERIMENTAL CELL RESEARCH (2015)
SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling
Mohammed A. Mansour et al.
FEBS JOURNAL (2015)
MAPK7 Regulates EMT Features and Modulates the Generation of CTCs
Sarah Javaid et al.
MOLECULAR CANCER RESEARCH (2015)
ERK5 positively regulates cigarette smoke-induced urocystic epithelial-mesenchymal transition in SV-40 immortalized human urothelial cells
Hao Geng et al.
ONCOLOGY REPORTS (2015)
Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation
A. E. S. Simoes et al.
CELL DEATH & DISEASE (2015)
Phosphorylation of ERK5 on Thr732 Is Associated with ERK5 Nuclear Localization and ERK5-Dependent Transcription
Takuto Honda et al.
PLOS ONE (2015)
XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism
Sripathi M. Sureban et al.
CANCER LETTERS (2014)
Novel Roles for ERK5 and Cofilin as Critical Mediators Linking ERα-Driven Transcription, Actin Reorganization, and Invasiveness in Breast Cancer
Zeynep Madak-Erdogan et al.
MOLECULAR CANCER RESEARCH (2014)
The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastoma
Ganesh Umapathy et al.
SCIENCE SIGNALING (2014)
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Limo Chen et al.
NATURE COMMUNICATIONS (2014)
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
Matthew Holderfield et al.
NATURE REVIEWS CANCER (2014)
Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients
Mercedes Herrera et al.
CANCER SCIENCE (2013)
E-cadherin-integrin crosstalk in cancer invasion and metastasis
Marta Canel et al.
JOURNAL OF CELL SCIENCE (2013)
MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis
James W. Antoon et al.
PLOS ONE (2013)
ERK5/BMK1 Is a Novel Target of the Tumor Suppressor VHL: Implication in Clear Cell Renal Carcinoma
Laura Arias-Gonzalez et al.
NEOPLASIA (2013)
MEK5/ERK5 pathway: The first fifteen years
Barbara A. Drew et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)
A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
J. Eberhard et al.
BRITISH JOURNAL OF CANCER (2012)
ERK5: Structure, regulation and function
Gopika N. Nithianandarajah-Jones et al.
CELLULAR SIGNALLING (2012)
Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2
Rumela Chakrabarti et al.
NATURE CELL BIOLOGY (2012)
ERK5 signalling in prostate cancer promotes an invasive phenotype
A. K. Ramsay et al.
BRITISH JOURNAL OF CANCER (2011)
Tyrosine phosphatases in the HER2-directed motility of ovarian cancer cells: Involvement of PTPN12, ERK5 and FAK
Emma Villa-Moruzzi
ANALYTICAL CELLULAR PATHOLOGY (2011)
Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway
Oliver A. Kent et al.
GENES & DEVELOPMENT (2010)
Transitions between epithelial and mesenchymal states and the morphogenesis of the early mouse embryo
Anna Ferrer-Vaquer et al.
CELL ADHESION & MIGRATION (2010)
Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells
Nancy E. Castro et al.
BREAST CANCER RESEARCH (2010)
A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis
Robert C. Doebele et al.
BLOOD (2009)
A Novel Role of ERK5 in Integrin-Mediated Cell Adhesion and Motility in Cancer Cells Via Fak Signaling
Rajinder S. Sawhney et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer
Shuang Wang et al.
JOURNAL OF PATHOLOGY (2009)
VHL Gene Mutations in Renal Cell Carcinoma: Role as a Biomarker of Disease Outcome and Drug Efficacy
C. Lance Cowey et al.
CURRENT ONCOLOGY REPORTS (2009)
HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathway
Maria E. Ramos-Nino et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
TGF-β activates ERK5 in human renal epithelial cells
James Alexander Browne et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
TGF-β induces formation of F-actin cores and matrix degradation in human breast cancer cells via distinct signaling pathways
Shyamali Mandal et al.
EXPERIMENTAL CELL RESEARCH (2008)
ERK5 promotes Src-induced podosome formation by limiting Rho activation
Mark Schramp et al.
JOURNAL OF CELL BIOLOGY (2008)
Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype
Changhua Zhou et al.
BREAST CANCER RESEARCH (2008)
Global gene expression analysis of ERK5 and ERK1/2 signaling reveals a role for HIF-1 in ERK5-mediated responses
Rebecca E. Schweppe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Multifunctional role of Erk5 in multiple myeloma
X Carvajal-Vergara et al.
BLOOD (2005)
Activation of either ERK1/2 or ERK5 MAP kinase pathways can lead to disruption of the actin cytoskeleton
JC Barros et al.
JOURNAL OF CELL SCIENCE (2005)
FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells
K Belguise et al.
ONCOGENE (2005)
Stat3 upregulates MEK5 expression in human breast cancer cells
H Song et al.
ONCOGENE (2004)
ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility
E Vial et al.
CANCER CELL (2003)
MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion
PB Mehta et al.
ONCOGENE (2003)
Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis:: dissection of Ras signaling pathways
E Janda et al.
JOURNAL OF CELL BIOLOGY (2002)
Share Paper
